1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study
of Diabetic Retinopathy. VI. Retinal photocoagulation. Ophthalmology. 1987; 94:747-53.
2. Miwa Y, Murakami T, Suzuma K, Uji A, Yoshitake S, Fujimoto M, Yoshitake T, Tamura
Y, Yoshimura N. Relationship between Functional and Structural Changes in Diabetic
Vessels in Optical Coherence Tomography Angiography. Sci Rep. 2016;6:29064; doi: 10.1038/srep29064.
3. Lee J, Rosen R. Optical Coherence Tomography Angiography in Diabetes. Curr Diab Rep.
2016;16:123.
4. Samara WA, Say EA, Khoo CT, Higgins TP, Magrath G, Ferenczy S, Shields CL. Correlation
of foveal avascular zone size with foveal morphology in normal eyes using optical
coherence tomography angiography. Retina. 2015;35:2188-95.
5. Di G, Weihong Y, Xiao Z, Zhikun Y, Xuan Z, Yi Q, Fangtian D. A morphological study
of the foveal avascular zone in patients with diabetes mellitus using optical coherence
tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2016;254:873-9.
6. Freiberg FJ, Pfau M, Wons J, Wirth MA, Becker MD, Michels S. Optical coherence tomography
angiography of the foveal avascular zone in diabetic retinopathy. Graefes Arch Clin
Exp Ophthalmol. 2016;254:1051-8.
7. Bowd C, Tafreshi A, Zangwill LM, Medeiros FA, Sample PA, Weinreb RN. Pattern electroretinogram
association with spectral domain-OCT structural measurements in glaucoma. Eye (Lond).
2011;25:224-32.
8. Gardner TW, Abcouwer SF, Barber AJ, Jackson GR. An integrated approach to diabetic
retinopathy research. Arch Ophthalmol. 2011;129:230-5.
9. Barber A J. Diabetic retinopathy: recent advances towards understanding neurodegeneration
and vision loss. Sci China Life Sci. 2015;58(6):541-9.
10. Jonsson K B, Frydkjaer-Olsen U, Grauslund J. Vascular Changes and Neurodegeneration
in the Early Stages of Diabetic Retinopathy: Which Comes First?. Ophthalmic Res.2016;56:1-9.
11. Wilkinson C P, Ferris F R, Klein R E, et al. Proposed international clinical diabetic
retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677-82.
12. Villarroel M, Ciudin A, Hernandez C, Simo R. Optical coherence tomography angiography
of the foveal avascular zone in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol.
2016;254:1051-8.
13. Takase N, Nozaki M, Kato A, Ozeki H, Yoshida M, Ogura Y. Engargement of foveal avascular
zone in diabetic eyes evaluated by en face optical coherence tomography angiography.
Retina. 2015;35:2377-83.
14. de Carlo T E, Chin A T, Bonini F M, et al. Detection of microvascular changes in eyes
of patients with diabetes but not clinial diabetic retinopathy using optical coherence
tomography angiography. Retina. 2015;35:2364-70.
15. Scarinci F, Jampol LM, Linsenmeier RA, Fawzi AA. Association of Diabetic Macular Nonperfusion
With Outer Retinal Disruption on Optical Coherence Tomography. JAMA Ophthalmol. 2015;133:1036-44.
16. Couturier A, Mane V, Bonnin S, Erginay A, Massin P, Gaudric A, Tadayoni R. Capillary
plexus anomalies in diabetic retinopathy on optical coherence tomography angiography.
Retina. 2015;35:2384-91.
17. Hegazy AI, Zedan RH, Macky TA, Esmat SM. Retinal ganglion cell complex changes using
spectral domain optical coherence tomography in diabetic patients without retinopathy.
Int J Ophthalmol. 2017;10:427-33.
18. Kurtenbach A, Flogel W, Erb C. Anomaloscope matches in patients with diabetes mellitus.
Graefes Arch Clin Exp Ophthalmol. 2002; 240:79-84
19. van Dijk H W, Verbraak F D, Kok P H, Garvin MK, Sonka M, Lee K, Devries JH, et al.
Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.
Invest Ophthalmol Vis Sci. 2010;51:3660-5.
20. Lima V C, Prata T S, Pacheco M A, et al. Macular Inner Retinal Layer Thinning in Diabetic
Patients Without Retinopathy Measured by Fourier Domain Optical Coherence Tomography.
Investigative Ophthalmology & Visual Science. 2010;51:341.
21. Antonetti D A, Klein R, Gardner T W. Diabetic retinopathy. N Engl J Med. 2012;366:1227-39.
22. Abcouwer S F, Gardner T W. Diabetic retinopathy: loss of neuroretinal adaptation to
the diabetic metabolic environment. Ann N Y Acad Sci. 2014;1311:174-90.
23. Chhablani J, Sharma A, Goud A, Peguda HK, Rao HL, Begum VU, et al. Neurodegeneration
in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography. Invest
Ophthalmol Vis Sci. 2015;56:6333-8.
24. van Dijk H W, Verbraak F D, Kok P H, Stehouwer M, Garvin MK, Sonka M, et al. Early
neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis
Sci. 2012;53:2715-9.